William Blair & Company
INFI

William Blair & Company’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

William Blair & Company’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-12,250
Closed -$25K – 1608
2017
Q4 		$25K Hold
12,250
– – ﹤0.01% 1350
2017
Q3 		$16K Sell
12,250
-1,075
-8% -$1.33K ﹤0.01% 1346
2017
Q2 		$21K Buy
13,325
+400
+3% +$771 ﹤0.01% 1524
2017
Q1 		$36K Sell
12,925
-255
-2% -$627 ﹤0.01% 1347
2016
Q4 		$18K Sell
13,180
-19,550
-60% -$25.5K ﹤0.01% 1317
2016
Q3 		$51K Sell
32,730
-400
-1% -$615 ﹤0.01% 1254
2016
Q2 		$44K Sell
33,130
-220,410
-87% -$1.03M ﹤0.01% 1199
2016
Q1 		$1.34M Buy
253,540
+4,789
+2% +$29.3K 0.01% 543
2015
Q4 		$1.95M Buy
248,751
+211,936
+576% +$1.82M 0.02% 477
2015
Q3 		$311K Sell
36,815
-11,385
-24% -$105K ﹤0.01% 1131
2015
Q2 		$527K Buy
+48,200
New +$619K ﹤0.01% 1740

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

William Blair & Company's INFI Position: Q1 2018 in Review

William Blair & Company sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2018, closing a stake of 12,250 shares — an estimated $25K sold.

William Blair & Company first reported a position in INFI in Q2 2015 and held it in 11 quarters. The position peaked at $1.95M in Q4 2015. 66 funds tracked by Wall St. Rank hold INFI as of Q1 2018.

  • William Blair & Company reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • William Blair & Company sold 12,250 Infinity Pharmaceuticals, Inc. shares in Q1 2018, an estimated $25K.
  • William Blair & Company first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2015 and held it in 11 quarters.
  • William Blair & Company's Infinity Pharmaceuticals, Inc. position peaked at $1.95M in Q4 2015.
  • 66 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2018.

Based on William Blair & Company's 13F filing for Q1 2018, filed 15 May 2018.